205 — BFB Health Income Statement
0.000.00%
Last trade - 00:00- HK$838.31m
- HK$669.63m
- HK$33.12m
Annual income statement for BFB Health, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 68.3 | 73.2 | 38.4 | 30.2 | 33.1 |
| Cost of Revenue | |||||
| Gross Profit | 41.7 | 41.2 | 11.2 | 12.4 | 16.2 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 98 | 156 | 71.7 | 35.1 | 52.4 |
| Operating Profit | -29.6 | -82.9 | -33.3 | -4.96 | -19.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -43.5 | -87.3 | -40.5 | -29.4 | -19.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -44.6 | -89.3 | -37.4 | -28.9 | -20 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -40.1 | -82.5 | -23.3 | -34.6 | -5.54 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -40.1 | -82.5 | -23.3 | -34.6 | -5.54 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.078 | -0.115 | -0.042 | -0.048 | -0.003 |